{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:17:33Z","timestamp":1787804253082,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jad-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jad.2014.11.005","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T08:10:49Z","timestamp":1416211849000},"page":"170-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Increased uric acid levels in bipolar disorder subjects during different phases of illness"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9781-4219","authenticated-orcid":false,"given":"Umberto","family":"Albert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"De Cori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Aguglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Barbaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Bogetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Maina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2014.11.005_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-5618.2006.00363.x","article-title":"Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial","volume":"8","author":"Akhondzadeh","year":"2006","journal-title":"Bipolar Disord."},{"issue":"7555","key":"10.1016\/j.jad.2014.11.005_bib2","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(68)92300-3","article-title":"Uric-acid metabolism in manic-depressive illness and during lithium therapy","volume":"1","author":"Anumonye","year":"1968","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jad.2014.11.005_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.coph.2007.09.002","article-title":"Adenosine as a neuromodulator in neurological diseases","volume":"8","author":"Boison","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jad.2014.11.005_bib4","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3233\/JAD-2010-1330","article-title":"Uric acid as a CNS antioxidant","volume":"19","author":"Bowman","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jad.2014.11.005_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrd2605","article-title":"Purinergic signaling and disorders of the central nervous system","volume":"7","author":"Burnstock","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2\u20133","key":"10.1016\/j.jad.2014.11.005_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.psychres.2009.07.012","article-title":"Increased risk of gout among patients with bipolar disorder: a nationwide population-based study","volume":"180","author":"Chung","year":"2010","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.jad.2014.11.005_bib7","first-page":"195","article-title":"Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder","volume":"22","author":"De Berardis","year":"2008","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.jad.2014.11.005_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-5618.2012.01001.x","article-title":"Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study","volume":"14","author":"Fan","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2014.11.005_bib9","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2014.11.005_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2014.11.005_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2013.06.038","article-title":"Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators","volume":"149","author":"Hirota","year":"2013","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.jad.2014.11.005_bib12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.euroneuro.2014.05.013","article-title":"In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder","volume":"24","author":"Jahangard","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2014.11.005_bib500","first-page":"981","article-title":"Increased uric acid levels in bipolar disorder: is it trait or state?","volume":"27","author":"Kesebir","year":"2013","journal-title":"J. Biol. Regul. Homeost. Agents."},{"key":"10.1016\/j.jad.2014.11.005_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2014.04.053","article-title":"Uric acid levels may be a biological marker for the differentiation of unipolar and bipolar disorder: the role of affective temperament","volume":"165","author":"Kesebir","year":"2014","journal-title":"J Affect. Disord."},{"key":"10.1016\/j.jad.2014.11.005_bib14","series-title":"Manic-Depressive Insanity and Paranoia","author":"Kraepelin","year":"1921"},{"key":"10.1016\/j.jad.2014.11.005_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.pnpbp.2006.02.002","article-title":"Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications","volume":"30","author":"Lara","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1-2","key":"10.1016\/j.jad.2014.11.005_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2009.05.023","article-title":"Association of serum uric acid levels with emotional and affective temperaments","volume":"121","author":"Lorenzi","year":"2010","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.jad.2014.11.005_bib17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2014.11.005_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/JCP.0b013e318268391d","article-title":"Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania","volume":"32","author":"Machado-Vieira","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2014.11.005_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/mehy.2001.1543","article-title":"Purinergic dysfunction in mania: an integrative model","volume":"58","author":"Machado-Vieira","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jad.2014.11.005_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2014.11.005_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2014.11.005_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejphar.2014.06.042","article-title":"Lithium: a review of pharmacology, clinical uses, and toxicity","volume":"740","author":"Oruch","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.jad.2014.11.005_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0920-1211(91)90070-V","article-title":"Plasma uric acid levels in patients receiving anticonvulsant monotherapy","volume":"8","author":"Ring","year":"1991","journal-title":"Epilepsy Res."},{"issue":"6","key":"10.1016\/j.jad.2014.11.005_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.pnpbp.2010.02.027","article-title":"Increased uric acid levels in drug-na\u00efve subjects with bipolar disorder during a first manic episode","volume":"34","author":"Salvadore","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.11.005_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.genhosppsych.2008.04.009","article-title":"Metabolic syndrome in Italian patients with bipolar disorder","volume":"30","author":"Salvi","year":"2008","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2014.11.005_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biopsych.2013.02.024","article-title":"Impulsivity in associated with uric acid: evidence from Humans and Mice","volume":"75","author":"Sutin","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.11.005_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bdi.12202","article-title":"Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and\/or antipsychotic agents in manic patients with bipolar disorder","volume":"16","author":"Weiser","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2014.11.005_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clinbiochem.2011.10.010","article-title":"Serum uric acid levels and the clinical characteristics of depression","volume":"45","author":"Wen","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jad.2014.11.005_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eurpsy.2013.05.006","article-title":"Gender-based differences in oxidative stress parameters do not underlie the the differences in mood disorders susceptibility between sexes","volume":"29","author":"Wiener","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2014.11.005_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271400706X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271400706X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T09:23:28Z","timestamp":1566033808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503271400706X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":31,"alternative-id":["S016503271400706X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2014.11.005","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased uric acid levels in bipolar disorder subjects during different phases of illness","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2014.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}